Open Accessibility Menu

Monthly investment news and growth insights — straight to your inbox. Sign up to our newsletter.

Tozaro

Life Sciences  •  East of England  •  Early Stage

Tozaro (previously MIP Discovery) designs and develops synthetic affinity reagents, with the aim of enhancing complex cell and gene therapy processes.

tozaro.com

Company
information

Total BGF investment

£2 million

Investment date

July 2020

Head office

Bedfordshire